217
Participants
Start Date
September 26, 2017
Primary Completion Date
May 4, 2018
Study Completion Date
May 15, 2018
TRC101
Oral suspension
Placebo
Oral suspension
Investigative Site 58, Flushing
Investigative Site 95, Atlanta
Investigative Site 57, Winter Park
Investigative Site 59, Hialeah
Investigative Site 54, Hollywood
Investigative Site 93, Hollywood
Investigative Site 92, Lauderdale Lakes
Investigative Site 51, Tampa
Investigative Site 53, Shreveport
Investigative Site 52, San Antonio
Investigative Site 55, Phoenix
Investigative Site 91, Los Angeles
Investigative Site 56, Chula Vista
Investigative Site 11, Sofia
Investigative Site 21, Zagreb
Investigative Site 31, Tbilisi
Investigative Site 32, Tbilisi
Investigative Site 33, Tbilisi
Investigative Site 34, Tbilisi
Investigative Site 35, Tbilisi
Investigative Site 36, Tbilisi
Investigative Site 37, Tbilisi
Investigative Site 43, Baja
Investigative Site 48, Balatonfüred
Investigative Site 41, Budapest
Investigative Site 46, Budapest
Investigative Site 45, Hatvan
Investigative Site 49, Hódmezővásárhely
Investigative Site 44, Kistarcsa
Investigative Site 42, Miskolc
Investigative Site 47, Mosonmagyaróvár
Investigative Site 64, Belgrade
Investigative Site 65, Belgrade
Investigative Site 61, Vršac
Investigative Site 62, Zrenjanin
Investigative Site 72, Jesenice
Investigative Site 71, Maribor
Investigative Site 81, Kharkiv
Investigative Site 83, Kharkiv
Investigative Site 87, Kharkiv
Investigative Site 88, Kharkiv
Investigative Site 84, Kyiv
Investigative Site 85, Kyiv
Investigative Site 86, Kyiv
Tricida, Inc.
INDUSTRY